Skip to content

Evaluation of Sestrin Levels in Patients With Endometriosis

The Sestrin Levels in Patients With Endometriosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04886037
Enrollment
90
Registered
2021-05-13
Start date
2021-02-01
Completion date
2021-07-20
Last updated
2021-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

sestrin

Brief summary

Serum sestrin levels of endometriosis patients are compared with a group of healthy volunteers of the same age.

Detailed description

Serum sestrin levels are compared with 45 endometriosis patients and 45 healthy volunteers of the same age. The energy metabolism of the endometriosis group and its possible relationship with the endometriosis stage will be compared since sestrin gives information about the energy metabolism of the people.

Interventions

OTHERsestrin

Serum sestrin levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group.

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* diagnosed with endometriosis (Surgery or ultrasound) * Women without endometriosis

Exclusion criteria

* Women without endometriosis * women who are only suspected endometriosis

Design outcomes

Primary

MeasureTime frameDescription
Serum sestrin levels in women with endometriosis6 monthsSerum sestrin levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group.

Secondary

MeasureTime frameDescription
Comparison of the relationship between serum sestrin level and endometriosis stage6 monthsBy comparing the relation of serum sestrin level with the stage of endometriosis, its relation with serum level in patients with advanced and early stage endometriosis will be examined. The possible effect of sestrin on disease pathogenesis will be examined.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026